A boy comes to your clinic with myopia in the right eye. Can you determine the cause? Medscape Ophthalmology
Author: Medscape
FDA OKs First Twice-Daily Steroid for Postsurgery Eye Pain
The nanoparticle formulation of loteprednol etabonate ophthalmic suspension (Inveltys, Kala Pharmaceuticals) is dosed two times daily rather than four times daily, with similar efficacy and safety. FDA Approvals
FDA Clears First Drug for Neurotrophic Keratitis
Cenegermin eye drops (Oxervate) are a recombinant form of human nerve growth factor that stimulate growth and survival of corneal epithelial cells. FDA Approvals
Blue Light Damages Retinal Cells in Lab Study
A cell-based experiment shows how blue light can damage retinal cells, but it’s unclear whether the results translate to humans or if blue light exposure from computers and cell phones harms vision. Medscape Medical News
AI in Ophthalmology: A Brave New World Coming
There’s a lot of hype about autonomous artificial intelligence systems, but are they anywhere near ready for prime time? Medscape Ophthalmology
FDA Clears Hydrus Microstent for Glaucoma
The Hydrus microstent used in conjunction with cataract surgery achieves significant and sustained lowering of intraocular pressure in patients with primary open-angle glaucoma. FDA Approvals
Three Eye Conditions Linked to Higher Alzheimer’s Risk
More insight into the eye as a ‘window into the brain’ comes from a study linking glaucoma, age-related macular degeneration, and diabetic retinopathy to a higher risk for Alzheimer’s disease. Medscape Medical News
Ocular Abnormalities in Congenital Zika Syndrome
This report details ocular abnormalities associated with Zika infection, underscoring the need for an early eye-screening exam for infants in which congenital Zika syndrome is suspected. Journal of Medical Case Reports
Bariatric Surgery Halves Microvascular Risk in Type 2 Diabetes
‘Such a remarkable decrease in microvascular complications has rarely been demonstrated by any form of diabetes therapy,’ write the authors of an editorial accompanying the study. Medscape Medical News
The Woman With Multiple Sclerosis and Blurry Vision
Why is this 65-year-old patient with relapsing-remitting MS having decreased vision in her right eye? Medscape Ophthalmology
Implant Poised to Transform Macular Degeneration Treatment
A system that delivers ranibizumab without injections could be a turning point for patients with neovascular age-related macular degeneration, results from the highly anticipated LADDER trial show. Medscape Medical News
Diabetic Retinopathy: Reality and Risk of Loss to Follow-up
Clinical studies on the treatments for diabetic retinopathy have focused on efficacy and safety, but the loss of patients to follow-up is a challenge that may be affected by the choice of treatment. Medscape Ophthalmology
For Dry Eye, Transnasal Neurostimulator Activates Real Tears
Drs Rapuano and Meghpara describe a unique new device that helps patients with dry eye produce their own tears. Wills Eye Hospital
Ophthalmologists on the Frontline of Neurologic Diagnosis?
New retina findings offer insights into brain disease. Medscape Neurology
Improving Accuracy for IOL Selection in Cataract Surgery
Find out about the recent advances that have led to improved accuracy in intraocular lens selection for cataract surgery. Current Opinion in Ophthalmology
PCA in Toric IOL Power Calculation: The New Kid on the Block
A new algorithm that incorporates posterior corneal astigmatism into toric intraocular lens power calculations shows promise. Medscape Ophthalmology
Anti-VEGF/PRP Regresses Diabetic Retinopathy
Taking a closer look at PROTEUS, an intriguing study in patients with high-risk proliferative diabetic retinopathy. Medscape Ophthalmology
Complications After Intravitreal Injection Aggravate
Inflammatory responses have unnerved some specialists, who have seen as many as six cases in one day and will discuss problems at the upcoming American Society of Retina Specialists meeting. Medscape Medical News
First Artificial Iris Approved
Following the recent approval by the US Food and Drug Administration (FDA) of the first artificial iris, Dr Brandon Ayres describes this groundbreaking solution for patients. Wills Eye Hospital
Mentoring Is ‘Good for Everyone’
Take some time to be a mentor. The benefits are immeasurable. Medscape Optometry